» Articles » PMID: 15178705

Endogenous Ligands of Toll-like Receptors

Overview
Journal J Leukoc Biol
Date 2004 Jun 5
PMID 15178705
Citations 257
Authors
Affiliations
Soon will be listed here.
Abstract

Extensive work has suggested that a number of endogenous molecules such as heat shock proteins (hsp) may be potent activators of the innate immune system capable of inducing proinflammatory cytokine production by the monocyte-macrophage system and the activation and maturation of dendritic cells. The cytokine-like effects of these endogenous molecules are mediated via the Toll-like receptor (TLR) signal-transduction pathways in a manner similar to lipopolysaccharide (LPS; via TLR4) and bacterial lipoproteins (via TLR2). However, recent evidence suggests that the reported cytokine effects of hsp may be a result of the contaminating LPS and LPS-associated molecules. The reasons for previous failure to recognize the contaminant(s) being responsible for the putative TLR ligands of hsp include failure to use highly purified hsp free of LPS contamination; failure to recognize the heat sensitivity of LPS; and failure to consider contaminant(s) other than LPS. Whether other reported putative endogenous ligands of TLR2 and TLR4 are a result of contamination of pathogen-associated molecular patterns is not clear. It is essential that efforts should be directed to conclusively determine whether the reported putative endogenous ligands of TLRs are a result of the endogenous molecules or of contaminant(s), before exploring further the implication and therapeutic potential of these putative TLR ligands.

Citing Articles

Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications.

Vafaeian A, Rajabi F, Rezaei N Heliyon. 2025; 11(3):e42226.

PMID: 40007792 PMC: 11850170. DOI: 10.1016/j.heliyon.2025.e42226.


Renal and Vascular Functional Decline in Aged Low Birth Weight Murine Adults.

Rabadi M, Verde M, Camilliere M, Vecchio N, Kandhi S, Sekulic M Kidney Blood Press Res. 2024; 49(1):1075-1090.

PMID: 39571568 PMC: 11652227. DOI: 10.1159/000542141.


Eye on the horizon: The metabolic landscape of the RPE in aging and disease.

Hansman D, Du J, Casson R, Peet D Prog Retin Eye Res. 2024; 104:101306.

PMID: 39433211 PMC: 11833275. DOI: 10.1016/j.preteyeres.2024.101306.


Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer.

Rahman M, Grice I, Ulett G, Wei M J Immunol Res. 2024; 2024:4312908.

PMID: 38962577 PMC: 11221958. DOI: 10.1155/2024/4312908.


Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review.

Khokhar M, Dey S, Tomo S, Jaremko M, Emwas A, Pandey R ACS Pharmacol Transl Sci. 2024; 7(6):1664-1693.

PMID: 38898941 PMC: 11184612. DOI: 10.1021/acsptsci.4c00067.